RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis/chronic fatigue syndrome

RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis/chronic fatigue syndrome

BackgroundThe energy metabolite oxaloacetate is significantly lower in the blood plasma of ME/CFS subjects. A previous open-label trial with oxaloacetate supplementation demonstrated a significant reduction in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-related fatigue.MethodsIn this...

Full description

Saved in:
Bibliographic Details
Main Authors: Alan Cash, Suzanne D. Vernon, Candace Rond, Lucinda Bateman, Saeed Abbaszadeh, Jennifer Bell, Brayden Yellman, David L. Kaufman
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Neurology
Subjects:
chronic fatigue syndrome
ME/CFS
oxaloacetate
fatigue
fatigue treatment
ME/CFS treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1483876/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2024.1483876/full

Similar Items